![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Midas Pharma Gmbh Ingelheim Am Rhein De, based in Germany, is a pharmaceutical company that stands out with its certifications from EDQM.
They are recognized for Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.
One of their significant offerings is Doxapram Hydrochloride, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2017-084 - Rev 00
This Chemical Type CEP, issued on July 17, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1201 associated with this CEP further emphasizes